Wockhardt announced a recall of 109,744 bottles of Metoprolol Succinate Extended-Release 50mg Tablets, the generic version of AstraZeneca’s Toprol XL.

This recall was initiated due to a dissolution test failure observed at the nine month time point. Dissolution tests verify the time taken for the active ingredient to release into the body, and help predict how the drug performs inside the body.

RELATED: More Safety Alerts and Recalls

The affected 50mg tablets are supplied in 30-count bottles and have Lot # LN10686, LN10687, LN10688, LN10707, LN10708 with an expiration date of 02/15. The recalled lots were manufactured at a Wockhardt plant in Mumbai, India.

Metoprolol Succinate is a beta-blocker indicated for the treatment of stable, symptomatic (NYHA Class II or III) ischemic, hypertensive, or cardiomyopathic heart failure; hypertension; and the long-term treatment of angina.

For more information call (800) 346-6854 or visit WockhardtUSA.com.